We have located links that may give you full text access.
JOURNAL ARTICLE
REVIEW
G-CSF-based stem cell therapy for the heart--unresolved issues part B: Stem cells, engraftment, transdifferentiation, and bioengineering.
Congestive Heart Failure 2007 November
The authors extend their coverage of recent developments in stem cell-based therapy for repairing the heart to cover the basic questions of what stem cells should be used and how best to favor their survivability within the injured heart. The authors focus their attention on those adult stem/progenitor cells that have been best investigated in animal studies for repairing the infarcted heart and are the focus of completed or ongoing clinical trials. In addition, they discuss the promise that resident cardiac stem cells offer and the recent identification of specialized architecturally defined niches within the heart to nurse their development. Bioengineering approaches employing off-the-shelf mesenchymal stem cell patches may soon provide a way to recreate these niches in the scarred heart. Conceivably, these patches might also be seeded with prescribed mixtures of culturally expanded autologous stem/progenitor cells that would lead to new blood vessel and cardiac myocyte formation. The convergence of bioengineering and molecular biology on stem cell therapy would seem to make what was once unimaginable, cardiac regeneration, a clinical reality in less than one generation.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app